Elisa Scarselli active positions
| Companies | Position | Start | End |
|---|---|---|---|
Nouscom AG
 Nouscom AG Pharmaceuticals: MajorHealth Technology Nouscom AG engages in the development of genetic neoantigen vaccines and oncolytic viruses for prevention and treatment of cancer. Its product pipeline include Nous-209, Nous-PEV, and Nous-THV-001. The company was founded by Alfredo Nicosia, Antonella Folgori, Riccardo Cortese, Stefano Colloca, Cinzia Traboni, Elisa Scarselli, and Gabriella Campadelli in 2007 and is headquartered in Basel, Switzerland. | Chief Tech/Sci/R&D Officer | 2006-12-31 | - |
| Founder | 2006-12-31 | - | |
| Nouscom Srl | Chief Tech/Sci/R&D Officer | 2014-12-31 | - |
| Founder | 2014-12-31 | - |
Career history of Elisa Scarselli
Statistics
International
| Switzerland | 2 |
| Italy | 2 |
Operational
| Chief Tech/Sci/R&D Officer | 2 |
| Founder | 2 |
Sectoral
| Health Technology | 2 |
| Commercial Services | 2 |
Positions held
Active
Inactive
Listed companies
Private companies
Linked companies
| Private companies | 2 |
|---|---|
Nouscom AG
Nouscom AG Pharmaceuticals: MajorHealth Technology Nouscom AG engages in the development of genetic neoantigen vaccines and oncolytic viruses for prevention and treatment of cancer. Its product pipeline include Nous-209, Nous-PEV, and Nous-THV-001. The company was founded by Alfredo Nicosia, Antonella Folgori, Riccardo Cortese, Stefano Colloca, Cinzia Traboni, Elisa Scarselli, and Gabriella Campadelli in 2007 and is headquartered in Basel, Switzerland. | Health Technology |
| Nouscom Srl | Commercial Services |
- Stock Market
- Insiders
- Elisa Scarselli
- Experience
